These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 12762831)

  • 21. Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae.
    Kosowska K; Credito K; Pankuch GA; Hoellman D; Lin G; Clark C; Dewasse B; McGhee P; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4113-9. PubMed ID: 15504829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrolide antibiotics.
    Pallasch TJ
    Dent Today; 1997 Nov; 16(11):72, 74-5, 78-9. PubMed ID: 9560736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Macrolides. New therapeutic prospects].
    Bryskier A; Labro MT
    Presse Med; 1994 Dec; 23(38):1762-6. PubMed ID: 7831266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, including effects of medium supplements and test conditions on MIC results.
    Biedenbach DJ; Jones RN; Lewis MT; Croco MA; Barrett MS
    Diagn Microbiol Infect Dis; 1999 Apr; 33(4):275-82. PubMed ID: 10212755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clarithromycin and azithromycin: new macrolide antibiotics.
    Piscitelli SC; Danziger LH; Rodvold KA
    Clin Pharm; 1992 Feb; 11(2):137-52. PubMed ID: 1312921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New macrolides].
    Portier H; Buisson M; Chavanet P
    Rev Prat; 1994 Jun; 44(12):1629-34. PubMed ID: 7939238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The newer macrolides. Azithromycin and clarithromycin.
    Zuckerman JM; Kaye KM
    Infect Dis Clin North Am; 1995 Sep; 9(3):731-45. PubMed ID: 7490441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Choosing the right macrolide antibiotic. A guide to selection.
    Charles L; Segreti J
    Drugs; 1997 Mar; 53(3):349-57. PubMed ID: 9074839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia.
    Zhanel GG; Hartel E; Adam H; Zelenitsky S; Zhanel MA; Golden A; Schweizer F; Gorityala B; Lagacé-Wiens PR; Walkty AJ; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2016 Dec; 76(18):1737-1757. PubMed ID: 27909995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review and comparison of advanced-generation macrolides clarithromycin and dirithromycin.
    McConnell SA; Amsden GW
    Pharmacotherapy; 1999 Apr; 19(4):404-15. PubMed ID: 10212011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clarithromycin. A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients.
    Langtry HD; Brogden RN
    Drugs; 1997 Jun; 53(6):973-1004. PubMed ID: 9179528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preliminary Study on Drug Susceptibility Profile and Resistance Mechanisms to Macrolides of Clinical Isolates of Non-tuberculous Mycobacteria from China.
    Li F; Li GL; Pang H; Liu HC; Xiao TY; Li SJ; Luo Q; Jiang Y; Wang RB; Wan KL
    Biomed Environ Sci; 2018 Apr; 31(4):290-299. PubMed ID: 29773092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrolide drug interactions: an update.
    Pai MP; Graci DM; Amsden GW
    Ann Pharmacother; 2000 Apr; 34(4):495-513. PubMed ID: 10772438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic drug interactions of macrolides.
    Periti P; Mazzei T; Mini E; Novelli A
    Clin Pharmacokinet; 1992 Aug; 23(2):106-31. PubMed ID: 1511528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential.
    Peters DH; Clissold SP
    Drugs; 1992 Jul; 44(1):117-64. PubMed ID: 1379907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity.
    Bosnar M; Kragol G; Koštrun S; Vujasinović I; Bošnjak B; Bencetić Mihaljević V; Marušić Ištuk Z; Kapić S; Hrvačić B; Brajša K; Tavčar B; Jelić D; Glojnarić I; Verbanac D; Culić O; Padovan J; Alihodžić S; Eraković Haber V; Spaventi R
    J Med Chem; 2012 Jul; 55(13):6111-23. PubMed ID: 22697905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy.
    Peters DH; Friedel HA; McTavish D
    Drugs; 1992 Nov; 44(5):750-99. PubMed ID: 1280567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clindamycin, erythromycin, and the newer macrolides.
    Raebel MA; Browne BA
    Clin Podiatr Med Surg; 1992 Apr; 9(2):409-23. PubMed ID: 1586909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The macrolide antibiotics: a pharmacokinetic and pharmacodynamic overview.
    Jain R; Danziger LH
    Curr Pharm Des; 2004; 10(25):3045-53. PubMed ID: 15544496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions of macrolide antibiotics (Erythromycin A, roxithromycin, erythromycylamine [Dirithromycin], and azithromycin) with phospholipids: computer-aided conformational analysis and studies on acellular and cell culture models.
    Montenez JP; Van Bambeke F; Piret J; Brasseur R; Tulkens PM; Mingeot-Leclercq MP
    Toxicol Appl Pharmacol; 1999 Apr; 156(2):129-40. PubMed ID: 10198278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.